Investigating effects of trazodone use on longitudinal cognitive change, Lead Investigator: Jeffrey Phillips Institution : Dept. of Neurology, University of Pennsylvania E-Mail : jefphi@mail.med.upenn.edu Proposal ID : 897 Proposal Description: Recent research in rodents (Halliday et al., 2017) suggests that trazodone, which is commonly prescribed for treatment of anxiety and depression, may have multiple therapeutic effects in neurodegenerative disease. Specifically, Halliday and colleagues reported alleviation of memory symptoms, prolonged survival, and slowing of neurodegeneration in mice treated with trazodone or dibenzoylmethane. The proposed mechanism of these therapeutic effects involves trazodone???s disruption of the unfolded protein response (UPR). The UPR is a protective response in which accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER) triggers a cessation of protein synthesis an overactive UPR characterizes a number of neurodegenerative diseases, including Alzheimer???s disease (AD) and frontotemporal dementia (FTD). Trazodone treatment may restore memory in mice by restarting protein transcription and returning cells to a state approximating healthy function. Prior research has already reported a beneficial effect of trazodone therapy on behavioral symptoms of frontotemporal dementia (Lebert et al., 2004) which is attributed to its antidepressant effects on serotonergic signaling (Hu et al., 2010). In contrast, the research of Halliday et al. (2017) suggests that potential benefits of trazodone may generalize to any neurodegenerative disease, including AD, that involves accumulation of misfolded proteins in the ER and consequent activation of the UPR. According a review of past or ongoing projects listed on the NACC website as well as an independent literature search, a targeted assessment of trazodone???s effects on longitudinal cognition, diagnostic change, and mortality in human dementia patients would represent a novel research project. In a 2013 study, Obermann et al.